Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

322 ARTÍCULOS , VIENDO DEL 256 AL 270

Turning principles into practice in Alzheimer's disease

Lindesay J, Bullock R, Daniels H, Emre M, Förstl H, Frölich L, Gabryelewicz T, Martínez-Lage P, Monsch AU, Tsolaki M, van Laar T.

Int J Clin Pract. 2010 Aug;64(9):1198-209. doi: 10.1111/j.1742-1241.2010.02417.x. Epub 2010 Jun 7.

Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease

Gauthier S, Lopez OL, Waldemar G, Jones RW, Cummings J, Zhang R, Schindler R, Schwam E.

Int Psychogeriatr. 2010 Sep;22(6):973-83. doi: 10.1017/S1041610210000888. Epub 2010 Jun 10.

Peaceful Mind: an open trial of cognitive-behavioral therapy for anxiety in persons with dementia

Paukert AL, Calleo J, Kraus-Schuman C, Snow L, Wilson N, Petersen NJ, Kunik ME, Stanley MA.

Int Psychogeriatr. 2010 Sep;22(6):1012-21. doi: 10.1017/S1041610210000694. Epub 2010 Jun 16.

Cortical oxygen supply during postural hypotension is further decreased in Alzheimer's disease, but unrelated to cholinesterase-inhibitor use

van Beek AH, Sijbesma JC, Jansen RW, Rikkert MG, Claassen JA.

J Alzheimers Dis. 2010;21(2):519-26. doi: 10.3233/JAD-2010-100288.

Regarding the ghosts of home care

Panasci J.

Care Manag J. 2010;11(2):91-2. doi: 10.1891/1521-0987.11.2.91.

The dramatic effects of Galantamine in a patient with early-onset Alzheimer's disease

Dev H, Agius M, Zaman R.

Psychiatr Danub. 2010 Jun;22(2):367-9.

[Memantine for treatment of behavioural disturbances and psychotic symptoms in moderate to moderately severe Alzheimer dementia: a naturalistic study in outpatient services in Austria]

Schmidt R, Baumhackl U, Berek K, Brücke T, Kapeller P, Lechner A, Rainer M, Stögerer EM.

Neuropsychiatr. 2010;24(2):125-31.

Memantine-related psychotic symptoms in a patient with bipolar disorder

Canan F, Ataoglu A.

J Clin Psychiatry. 2010 Jul;71(7):957. doi: 10.4088/JCP.09l05802gry.

[Drug therapy for Alzheimer's disease]

Shoji M.

Brain Nerve. 2010 Jul;62(7):777-85.

[Caring for patients with Alzheimer's disease]

Hirono N.

Brain Nerve. 2010 Jul;62(7):797-802.

Technology-aided verbal instructions to help persons with mild or moderate Alzheimer's disease perform daily activities

Lancioni GE, Singh NN, O'Reilly MF, Sigafoos J, Tatulli E, Rigante V, Zonno N, Perilli V, Pinto K, Minervini MG.

Res Dev Disabil. 2010 Nov-Dec;31(6):1240-50. doi: 10.1016/j.ridd.2010.07.021. Epub 2010 Aug 8.

Cognitive intervention in Alzheimer disease

Buschert V, Bokde AL, Hampel H.

Nat Rev Neurol. 2010 Sep;6(9):508-17. doi: 10.1038/nrneurol.2010.113. Epub 2010 Aug 17.

Why are drug trials in Alzheimer's disease failing?

Lancet. 2010 Aug 28;376(9742):658. doi: 10.1016/S0140-6736(10)61316-5.

Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial

Akhondzadeh S, Sabet MS, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi SSh, Yousefi MH, Alimardani R, Jamshidi A, Zare F, Moradi A.

J Clin Pharm Ther. 2010 Oct;35(5):581-8. doi: 10.1111/j.1365-2710.2009.01133.x.

EFNS guidelines for the diagnosis and management of Alzheimer's disease

Hort J, O'Brien JT, Gainotti G, Pirttila T, Popescu BO, Rektorova I, Sorbi S, Scheltens P; EFNS Scientist Panel on Dementia.

Eur J Neurol. 2010 Oct;17(10):1236-48. doi: 10.1111/j.1468-1331.2010.03040.x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias